They're calling it "silent" because the wave follows a long period of unusually low COVID activity this fall, so many people ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

Shares of BioNTech slipped 0.83% in after-hours trading on Friday after the company said it would pay $791.5 million in a ...

Dr. José Fusillo, a well-known pro-vaccine pulmonologist from Paraguay, has passed away unexpectedly from a stroke, raising questions about the ongoing discourse surrounding vaccines. Fusillo was ...

The celebrity doctor looks on track to join Trump’s cabinet after a bruising 2022 Senate defeat in Pennsylvania.

Discover CDC findings on COVID-19 variants and vaccine protection, revealing key insights into emerging strains and public ...

Last year, Moderna ( NASDAQ: MRNA) made headlines with its individualized mRNA cancer vaccine mRNA-4157 (V940), developed ...

Additionally, the total funding currently allotted to the Phase 2b comparative study, comparing Vaxart’s oral pill XBB COVID-19 vaccine candidate with an FDA-approved mRNA vaccine, has been increased ...

The US hasn’t learned lessons from the Covid-19 pandemic that it could use to mitigate the threat of pathogens like H5N1 bird ...

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

As previously disclosed on June 13, 2024, Vaxart, Inc. entered into an agreement with Advanced Technology International, the Consortium Management Firm of the Rapid Response Partnership Vehicle funded ...